XCUR on Nasdaq

EXICURE, INC.

American pharmaceutical preparations company based in Wilmington.

Price unavailable

Last updated Oct 18, 2026.

Overview

Compare with Catabasis Pharmaceuticals, DiaMedica Therapeutics Inc. or Imunon, Inc., or pick any stock.

  • TickerXCUR on Nasdaq
  • IndustryPharmaceutical Preparations
  • HeadquartersWilmington, United States
  • Incorporated inDE2
  • Business address2430 N. Halsted St., Chicago, Il 606142
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-100.0%Revenue growth, 20253
-126.0%Return on equity3
-$8.6MFree cash flow3

Financial statements

Revenue45673$0 in 2025
-$10.0M0$10.0M$20.0M$30.0M2019: $1.3M$1.3M20192020: $16.6M$16.6M2020+1182%2021: -$483.0K-$483.0K20212022: $28.8M$28.8M20222023: $0$020232024: $500.0K$500.0K20242025: $0$02025
Operating income485673-$4.2M in 2025−84% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$26.6M-$26.6M20192020: -$25.4M-$25.4M2020−4%2021: -$62.5M-$62.5M2021+146%2022: -$1.8M-$1.8M2022−97%2023: -$15.0M-$15.0M2023+719%2024: -$12.2M-$12.2M2024−18%2025: -$4.2M-$4.2M2025−65%
Net income485673-$4.9M in 2025−81% since 2019
-$80.0M-$60.0M-$40.0M-$20.0M02019: -$26.3M-$26.3M20192020: -$24.7M-$24.7M2020−6%2021: -$64.1M-$64.1M2021+160%2022: -$2.6M-$2.6M2022−96%2023: -$16.9M-$16.9M2023+555%2024: -$9.7M-$9.7M2024−43%2025: -$4.9M-$4.9M2025−49%

Every line of the income statement as filed: the last 2 fiscal years, latest first.3

Period ending2025-12-312024-12-31
Revenue$0$500.0K
Total revenue$0$500.0K
Research and development expense$3.3M$0
General and administrative expense$6.8M$5.4M
Litigation legal expense$0$1.6M
Right-of-use asset impairment loss$0$5.7M
Loss from sale of property and equipment$90.0K$0
Gain on early lease termination-$6.0M$0
Total operating expenses$4.2M$12.7M
Operating loss-$4.2M-$12.2M
Dividend income$107.0K$5.0K
Interest income$29.0K$8.0K
Interest expense-$1.0K-$18.0K
Gain on settlement of accounts payables$346.0K$407.0K
Change in fair value of contingent liability-$1.6M$0
Other income (expense), net-$275.0K$2.1M
Total other income (expense), net-$1.3M$2.5M
Net loss before provision for income taxes-$5.6M-$9.7M
Provision (benefit) for income taxes-$634.0K$8.0K
Net loss-$4.9M-$9.7M
Basic loss per common share (in USD per share)-$0.79-$4.75
Diluted loss per common share (in USD per share)-$0.79-$4.75
Weighted-average basic common shares outstanding (in shares)6.3M shares2.0M shares
Weighted-average diluted common shares outstanding (in shares)6.3M shares2.0M shares

Compare EXICURE, INC. with another company

Leadership

Who has led EXICURE, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. David A. Giljohann2017–2021
  2. Matthias Schroff2022
  3. Josh Miller2023

Chief financial officer

  1. David S. Snyder2017–2020
  2. Brian Bock2021
  3. Elias D. Papadimas2022
  4. Josh Miller2023

Chief operating officer

  1. Matthias Schroff2018–2021
20202025
Board members and other officers (37)

Former names

  • Max-1 Acquisition CorpMar 21, 2017 to Sep 28, 20172

Timeline

  1. May 9, 2023New chief executive Josh Miller becomes CEO11
  2. May 18, 2022New chief executive Matthias Schroff becomes CEO12
  3. Sep 28, 2017New chief executive David A. Giljohann becomes CEO13
  4. Feb 6, 2017Founded EXICURE, INC. is founded51

Filings

256 filings to the SEC since October 2021: 6 annual reports, 19 quarterly reports, 102 major events, 62 insider forms, 34 large holders, 33 other. The latest 20:

  1. Sep 16, 20268-K EDGAR
  2. Aug 14, 202610-Q EDGAR
  3. Jul 17, 20264 PRIMARY DOCUMENT EDGAR
  4. Jul 17, 2026SCHEDULE 13D/A EDGAR
  5. Jun 30, 20268-K EDGAR
  6. Jun 1, 20268-K EDGAR
  7. May 29, 202610-Q EDGAR
  8. May 15, 2026NT 10-Q EDGAR
  9. Apr 10, 20268-K EDGAR
  10. Apr 2, 20268-K EDGAR
  11. Mar 27, 20268-K EDGAR
  12. Mar 25, 202610-K EDGAR
  13. Mar 25, 20268-K EDGAR
  14. Feb 19, 20264 EDGAR
  15. Feb 17, 20268-K EDGAR
  16. Feb 10, 20268-K EDGAR
  17. Jan 22, 20268-K EDGAR
  18. Jan 21, 2026SCHEDULE 13D/A EDGAR
  19. Jan 21, 20264 PRIMARY DOCUMENT EDGAR
  20. Jan 20, 2026SCHEDULE 13D/A EDGAR

The 256 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 34 such filings since October 2021, the latest 10:

  1. Jul 17, 2026SCHEDULE 13D/A
  2. Jan 21, 2026SCHEDULE 13D/A
  3. Jan 20, 2026SCHEDULE 13D/A
  4. Jan 9, 2026SCHEDULE 13D/A
  5. Dec 10, 2025SCHEDULE 13G/A
  6. Sep 22, 2025SCHEDULE 13D/A
  7. Mar 26, 2025SCHEDULE 13D/A
  8. Dec 23, 2024SCHEDULE 13G
  9. Nov 29, 2024SC 13D
  10. Sep 16, 2024SC 13D/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Vanguard Capital Management LLC43,111$89.7K0.0%+10,128
Geode Capital Management, LLC31,249$65.0K0.0%−5,664
Jane Street Group, LLC29,535$61.4K0.0%New
Citadel Advisors LLC14,919$31.0K0.0%New
Vanguard Fiduciary Trust Co13,161$27.4K0.0%No change
Tower Research Capital LLC (TRC)4,074$8.5K0.0%+3,585
UBS Group AG342$7110.0%−524
Morgan Stanley143$2970.0%−15
SBI Securities Co., Ltd.43$890.0%No change
BlackRock, Inc.35$730.0%−9,318
Osaic Holdings, Inc.29$600.0%No change
Prestige Wealth Management Group LLC20$420.0%No change
Harbour Investments, Inc.17$350.0%No change
Caitong International Asset Management Co., Ltd6$120.0%+5
Bnp Paribas Financial Markets4$80.0%No change
Jpmorgan Chase & Co2$40.0%No change
Royal Bank Of Canada82$00.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51